期刊文献+

先天性肾上腺皮质增生风险胎儿的CYP21基因分子产前诊断 被引量:1

Molecular Prenatal Diagnosis of a Fetus at the Risk of Congenital Adrenal Hyperplasia with Mutation of CYP21 Gene
下载PDF
导出
摘要 目的报告1例先天性肾上腺皮质增生(CAH)CYP21基因缺陷风险胎儿的分子产前诊断。方法首先对携带者夫妇进行CYP21基因扩增和测序,确定这对夫妇均为CYP21基因缺陷的携带者。妻子孕29w时于B超的引导下抽取胎儿脐血,分离血浆进行17-羟孕酮的检测。从血细胞中提取DNA,用多态性住点D12S1701检测夫妇和胎儿DNA,以排除胎儿样本中无母体细胞污染,在此基础上,针对携带者突变位点对胎儿样本进行DNA扩增,PCR产物经正反方向测序分析。结果携带者夫妇均存在CYP21因子外显子4突变(g.1122T〉A,p.1172N)和外显子6的丛集突变(g.1503T〉A,g.1506T〉A,g.1512T〉A,p.1236N,p.V237E,p.M239K)。多态性位点检测排除胎儿样本中母体细胞污染,胎儿测序结果显示不带有与父母相同的突变。胎儿血浆17-羟孕酮结果正常。最后妻子足月分娩了一健康女婴。结论产前分子诊断对于CAH风险胎儿是非常重要的。用测序技术进行CYP21基因的分子产前诊断是可行的。 Objective Molecular prenatal diagnosis of a fetus at the risk of congenital adrenal hyperplasia(CAH) with mutation of CYP21 gene was reported. Methods Molecular diagnosis of CYP21 gene was performe by sequencing for the couple at first. After confirming the mutations of the couple, fetal genomie DNA was extracted from an umbilical blood sample obtained by puncturing at 29 weeks of gestation under guidance of ultrasound scan. Blood plasma was separated from the umbilical blood sample for analyzing the level of 17-hydroxyprogesterone (17-OHP). Polymorphic analysis with locus D12S1701 was performed to exclude maternal contamination. PCR amplification of fetal DNA on exons 4 and 6 in CYP21 gene was carried out and their products were sequenced directly. Results The tandem mutations of exon 4 (g. 1122 T〉A,p. I172N) and exon 6 (g. 1503 T〉A,g. 1506 T〉A,g. 1512 T〉A,p. I236N,p. V237E,p. M239K) were detected on one allele from the couple, Maternal contamination was excluded by polymorphic analysis with locus D12S1701. The fetal results showed no mutation of exons 4 and 6 in CYP21 gene was found,identifying the fetus was carrying normal alleles without the same mutation as her parents. The fetal level of 17-OHP was normal,which was consistent with molecular result. Recently,a normal girl was born at 39 weeks of gestation, which confirmed that the technique was reliable for molecular prenatal diagnosis of CYP21 gene. Conclusion Molecular prenatal diagnosis is practical and for fetus at risk with CAH.
出处 《现代检验医学杂志》 CAS 2009年第5期15-18,共4页 Journal of Modern Laboratory Medicine
基金 江苏省科技厅技术平台资金资助(编号:BM2008151).
关键词 先天性肾上腺皮质增生 21-羟化酶 分子产前诊断 congenital adrenal hyperplasia 21-hydroxylase molecular prenatal diagnosis
  • 相关文献

参考文献18

  • 1Witchel SF,Lee PA, Suda-Hartman M, et al. Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J]. J Clin Endocrinol Metab, 1997, 82 (7): 2097- 2101.
  • 2Nordenstrom A,Thilen A ,Hagenfeldt L ,et al. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency [J]. J Clin Endocrinol Metab, 1999,84 (5) : 1505-1509.
  • 3Speiser PW,Dupont B,Rubinstein P,et al. High frequency of nonclassical steroid 21-hydroxylase deficiency[J]. Am J Hum Genet, 1985,37 (4) :650-667.
  • 4Merke DP,Bornstein SR. Congenital adrenal hyperplasia[J]. Lancet ,2005,365 (9477) : 2125-2136.
  • 5崔英霞,黄蓓,史轶超,卢洪涌,夏欣一,潘连军,黄宇烽.2例潜在染色体病风险妊娠的产前诊断[J].中华男科学杂志,2007,13(7):624-627. 被引量:3
  • 6White PC,Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J]. Endocr Rev, 2000,21 (3) : 245-291.
  • 7Robins T, Barbaro M, Lajic S,et al. Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia [J]. J Clin Endocrinol Metab, 2005, 90 (4): 2148- 2153.
  • 8Higashi Y,Tanae A,Inoue H,et al. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450 (C21)] deficiency in humans : possible gene conversion products[J]. Proc Natl Acad Sci U S A, 1988,85(20) : 7486-7490.
  • 9Ohlsson G, Muller J, Skakkebaek NE, et al. Steroid 21-hydroxylase deficiency: mutational spectrum in Denmark,three novel mutations ,and in vitro expression analysis[J]. Hum Mutat, 1999,13(6) : 482-486.
  • 10Levo A,Partanen J. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles [ J]. Hum Genet, 1997, 99 (4): 488- 497.

二级参考文献12

  • 1崔英霞,夏欣一,郝丽君,潘连军,王国洪,王云华,梁泉,黄宇烽.1例与Y染色体畸变相关的无性腺症、矮身材和蹠骨畸形[J].中华男科学杂志,2006,12(9):839-841. 被引量:2
  • 2Lee H,Human Genet,1998年,103卷,304310页
  • 3Lee H,J Med Genet,1996年,33卷,371375页
  • 4Pang S,New England J Medicine,1990年,322卷,111页
  • 5Pang S,Pediatrics,1988年,81卷,866页
  • 6Smioni M,Bakker E,Krausz C.EAA/EMQN best practice guide-lines for molecular diagnosis of Y-chromosomal microdeletions.State of the art 2004[J].Int J Androl,2004,27(4):240-249.
  • 7Stene J,Stene E,Mikkelsen M.Risk for chromosome abnormality at amniocentesis following a child with a non-inherited chromosome aberration.A European Collaborative Study on Prenatal Diagnoses 1981[J].Prenat Diagn,1984 Spring;4 Spec No:81-95.
  • 8Campbell SA,Uhlmann WR,Duquette D,et al.Pregnancy outcome when both members of a couple have balanced translocations[J].Obstet Gynecol,1995,85(5 Pt 2):844-846.
  • 9Baty J,Brent BL,Carey JC.Nature history of trisomy 18 and trisomy 13:I.Growth,physical assessment,medical histories,survival and recurrence risk[J].Am J Med Gemet,1994,49(2):175-188.
  • 10Lee HH, Kuo JM, Chao HT, et al. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21- hydroxylase deficiency in chinese. J Clin Endocrinol Metab,2000, 85:597-600.

共引文献10

同被引文献14

  • 1兰风华,黄梁浒,杨渤生.肾上腺脑白质营养不良的分子诊断与分子机制[J].东南国防医药,2005,7(5):321-323. 被引量:9
  • 2黄梁浒,黄惠娟,杨渤生,涂向东,曾健,李慧忠,辛娜,兰风华.肾上腺脑白质营养不良的产前分子诊断(英文)[J].中华医学遗传学杂志,2005,22(6):612-615. 被引量:3
  • 3Yu Y, Wang J, Huang X, et al. Molecular characterization of 25 Chinese pedigrees with 21-hydroxylase deficiency[ J]. Genet Test Mol Biomarkers,2011,15 (3) : 137-142.
  • 4Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21 hydroxylase deficiency [ J ]. Hum Reprod Update ,2004,10 ( 6 ) :469-485.
  • 5Ghizzoni L, Cesari S, Cremonini G, et al. Prenatal and early post- natal treatment of congenital adrenal hyperplasia [ J ]. Endoer Dev, 2007,11:58-69.
  • 6Hindmarsh PC. Management of the child with congenital adrenal hyperplasia[ J]. Best Praet Res Clin Endoerinol Metab,2009,23: 193-208.
  • 7Yokoyama Y, Teraoka M, Tsuji K, et el. Rapid screening method to detect mutations in CYP21, the gene for 21-hydmxylase [ J ]. Am J Med Genet,2000,94 ( 1 ) :28-31.
  • 8Wedell A. Congenital adrenal hyperplasia [ J ]. Clin Biochem, 2011,44(7) :505-506.
  • 9Wedell A, Thil6n A, Ritz6n EM, et al . Mutational spectrum of the steroid 21-hydroxylase gene in Sweden:implications for genetic di- agnosis and association with disease manifestation [ J ]. J Clin En- docrinol Metab, 1994,78 (5) : 1145-52.
  • 10Lee HH, Kuo JM, Chao HT, et al. Carrier analysis and prenatal di- agnosis of congenital adrenalhyperplasia caused by 21-hydroxylase deficiency in chinese [ J ]. J Clin Endocrinol Metab, 2000,85 : 597- 600.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部